Trials / Completed
CompletedNCT03290300
Quality of Life Impact of Nasal Airway Treatment With Aerin Medical Device
A Prospective, Multi-Center, Non-Randomized Study to Evaluate the Quality of Life Impact After Treatment of Nasal Airway Obstruction Using the Aerin Medical Vivaer Stylus
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 39 (actual)
- Sponsor
- Aerin Medical · Industry
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Not accepted
Summary
Evaluation of long-term (5-year) quality of life after nasal airway obstruction treatment with the Aerin Vivaer Stylus
Detailed description
This is a prospective, non-randomized, multi-center follow-up study to collect long term quality of life (QOL) data on a cohort of patients who participated in the Aerin Medical TP258 study "A Prospective, Multi-Center, Non-Randomized Study to Evaluate Treatment of Nasal Airway Obstruction Using the Aerin Medical Device". The TP258 study followed subjects out to 26 weeks post-procedure. This QOL study will collect data at 12, 18, 24, 36, 48 and 60 months post-procedure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Vivaer Stylus | Previous nasal obstruction treatment with the Aerin Medical Vivaer Stylus |
Timeline
- Start date
- 2017-10-30
- Primary completion
- 2022-07-09
- Completion
- 2022-07-09
- First posted
- 2017-09-21
- Last updated
- 2024-02-15
- Results posted
- 2019-08-19
Locations
8 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03290300. Inclusion in this directory is not an endorsement.